Literature DB >> 12195764

Pain mechanisms involved and outcome in advanced cancer patients with possible indications for celiac plexus block and superior hypogastric plexus block.

Sebastiano Mercadante1, Fabio Fulfaro, Alessandra Casuccio.   

Abstract

AIMS AND
BACKGROUND: There is controversy about the role of neurolytic sympathetic blocks in advanced cancer, when pain syndromes may assume other characteristics, with a possible involvement of structures other than visceral. The aim of the present study was to assess the pain characteristics and the analgesic response of a consecutive sample of home care patients with pancreatic and pelvic pain, which would have possible indications for a celiac plexus block and a superior hypogastric block, respectively.
METHODS: From January 1999 to December 1999, 400 consecutive advanced cancer patients were surveyed for a prospective longitudinal survey. We considered only patients who had pancreatic cancer or pelvic cancer with pain.
RESULTS: Thirty-six patients were surveyed: 22 patients had pelvic cancers and 14 had pancreatic cancer. Patients with pelvic cancers showed a longer survival than those with pancreatic cancer (P = 0.019). Patients with pelvic cancers more frequently showed a neuropathic component associated with a visceral or somatic mechanism than patients with pain due to pancreatic cancer (P = 0.019). When the pain mechanism was taken into consideration, patients with pelvic cancers with a neuropathic component showed worse pain relief than patients with pain due to pancreatic cancer (P = 0.040).
CONCLUSIONS: Sympathetic procedures for pain conditions due to pancreatic and pelvic cancers should be intended as adjuvant techniques to reduce the analgesic consumption, and not as a panacea, given that multiple pain mechanisms are often involved because progression of disease is able to change the underlying pain mechanisms. Pancreatic pain seems to maintain visceral characteristics amenable to sympathetic block more than pain due to pelvic cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12195764     DOI: 10.1177/030089160208800311

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  5 in total

1.  Effect of neurolytic celiac plexus block guided by computerized tomography on pancreatic cancer pain.

Authors:  Chun-Lei Zhang; Ting-Jie Zhang; Yu-Na Guo; Li-Qiang Yang; Ming-Wei He; Jing-Zhe Shi; Jia-Xiang Ni
Journal:  Dig Dis Sci       Date:  2007-08-04       Impact factor: 3.199

Review 2.  The role of chemical neurolysis in cancer pain.

Authors:  Dhanalakshmi Koyyalagunta; Allen W Burton
Journal:  Curr Pain Headache Rep       Date:  2010-08

3.  Chemical neurolysis of the inferior hypogastric plexus for the treatment of cancer-related pelvic and perineal pain.

Authors:  Sahar Abd-Elbaky Mohamed; Doaa Gomaa Ahmed; Mohamad Farouk Mohamad
Journal:  Pain Res Manag       Date:  2013-05-28       Impact factor: 3.037

4.  Commentary: Interpreting Data of Celiac Plexus Block in Patients with Pancreatic Pain: Timing, Patients, Survival.

Authors:  Sebastiano Mercadante
Journal:  Pain Ther       Date:  2022-05-27

5.  The Role of Double Modality Ultrasonographic and Fluoroscopic Guided Superior Hypogastric Plexus Neurolysis in Treating Intractable Pelvic Cancer Pain: A Comparative Study.

Authors:  Ekramy M Abdelghafar; Ahmed H Othman; Mahmoud Salem Soliman; Ayman Kilany; Mohammed H Shaaban; Ehab H Shaker
Journal:  J Pain Res       Date:  2021-05-27       Impact factor: 3.133

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.